← Library
Madras High CourtA/9118/2018closed

Daimler Financial Services India Pvt Ltd. v. Santhosh Kumar Yadav

2020-07-08Honourable Mr Justice N. Sathish Kumar3 pages

IN THE HIGH COURT OF JUDICATURE AT MADRAS

DATED: 08.07.2020

CORAM:

THE HONOURABLE MR.JUSTICE N.SATHISH KUMAR Daimler Financial Services India Pvt.Ltd., Unit 202, 2nd Floor, Campus 3B, RMZ Millennia Business Park, 143, Dr MGR Road, Perungudi, Chennai - 600 096, India, Rep by its Legal Executive Mr.K.Ramakrishna . . . Applicant

Versus

Santhosh Kumar Yadav, H.No.126 Makdoompur, Gomti Nagar, Lucknow, Uttar Pradesh.

. . . Respondent PRAYER: Application filed under Order XIV Rule 8 of original side rules r/w.SEC 9(ii)(e) of the Arbitration and Conciliation Act, 1996, to appoint Mr.Pankaj Kumar Singh, S/o. Jagannath Singh, Authorized Agent of the applicant as Receiver to seize and take possession of the subject schedule vehicle more fully described in the Schedule of the Judge's Summons from the premises of the respondents or wherever found with police aid and break open of premises if necessary.

For Applicant :

Mr.H.Mohamed Ismail For Respondent :

No appearance

ORDER

By order dated 04.12.2018, this Court had appointed one Mr.M.Mohamed Muzammil, learned Advocate as Advocate Commissioner to seize and possess the vehicle, which is morefully described in the schedule to the Judges Summons. 2.

Today, when the matter was called, the learned counsel appearing for the applicant submitted that the vehicle could not be secured and sought for extension of time for execution of order by the Advocate Commissioner and submitted that further time of four weeks may be granted to repossess the vehicle.

3. Accordingly, time is extended finally for a period of four weeks from the date of receipt of a copy of this order, failing which the Order granting power to repossess the vehicle shall automatically stand cancelled. 4.

With the above direction, the application is closed. 08.07.2020 Index : Yes/No Internet : Yes/No Speaking/Non Speaking gsk

N.SATHISH KUMAR, J.

gsk 08.07.2020